Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06SBS
|
|||
Former ID |
DPR000113
|
|||
Drug Name |
SSR-504734
|
|||
Synonyms |
2-chloro-N-[(R)-phenyl-(2-piperidyl)methyl]-3-(trifluoromethyl)benzamide Hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Schizophrenia [ICD-11: 6A20] | Preclinical | [1] | |
Company |
Sanofi-Aventis
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H20ClF3N2O
|
|||
Canonical SMILES |
C1CCNC(C1)C(C2=CC=CC=C2)NC(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl
|
|||
InChI |
1S/C20H20ClF3N2O/c21-17-14(9-6-10-15(17)20(22,23)24)19(27)26-18(13-7-2-1-3-8-13)16-11-4-5-12-25-16/h1-3,6-10,16,18,25H,4-5,11-12H2,(H,26,27)/t16-,18-/m0/s1
|
|||
InChIKey |
MEZRZVWPLXVLSO-WMZOPIPTSA-N
|
|||
CAS Number |
CAS 742693-38-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glycine transporter GlyT-1 (SLC6A9) | Target Info | Blocker | [1] |
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | NRF2 pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.